NTLA : Intellia Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-03-24 |
|---|---|---|---|---|
| 2023 | $37.94 | $37.6 | $38.57 | -0.95% |
| 2024 | $39.88 | $38.71 | $41.08 | 4.13% |
| 2025 | $46.73 | $42.09 | $49.38 | 22.01% |
| 2026 | $54.46 | $49.75 | $60.89 | 42.2% |
| 2027 | $66.54 | $61.83 | $71.68 | 73.73% |
| 2028 | $74.77 | $72.63 | $76.01 | 95.23% |
| 2029 | $75.85 | $75.05 | $76.16 | 98.04% |
| 2030 | $73.26 | $70.95 | $74.78 | 91.28% |
| 2031 | $52.74 | $35.07 | $69.72 | 37.69% |
| 2032 | $27.97 | $24.69 | $33.53 | -26.96% |
| 2033 | $24.0 | $23.67 | $24.35 | -37.34% |
The 31 Wall Street analysts offering Intellia Therapeutics stock forecast in the last 6 months have average price target of
$97.23 with a high forecast of $130.0 and a low forecast of $39.0.
The average Intellia Therapeutics stock forecast represents a 153.86%
increase from the last price of $38.2999992370605.
From AI system, total return is 2366.52% from 4098 forecasts.
For Intellia Therapeutics stock forecast for 2023, 9 predictions are offered for each month of 2023 with average Intellia Therapeutics stock
forecast of $37.94, a high forecast of $38.57, and a low forecast of $37.6.
The average Intellia Therapeutics stock forecast 2023 represents a -0.95%
decrease from the last price of $38.2999992370605.
For Intellia Therapeutics stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Intellia Therapeutics stock
forecast of $39.88, a high forecast of $41.08, and a low forecast of $38.71.
The average Intellia Therapeutics stock forecast 2024 represents a 4.13%
increase from the last price of $38.2999992370605.
For Intellia Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Intellia Therapeutics stock
forecast of $54.46, a high forecast of $60.89, and a low forecast of $49.75.
The average Intellia Therapeutics stock forecast 2026 represents a 42.2%
increase from the last price of $38.2999992370605.
For Intellia Therapeutics stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Intellia Therapeutics stock
forecast of $74.77, a high forecast of $76.01, and a low forecast of $72.63.
The average Intellia Therapeutics stock forecast 2028 represents a 95.23%
increase from the last price of $38.2999992370605.
For Intellia Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Intellia Therapeutics stock
forecast of $52.74, a high forecast of $69.72, and a low forecast of $35.07.
The average Intellia Therapeutics stock forecast 2031 represents a 37.69%
increase from the last price of $38.2999992370605.
For Intellia Therapeutics stock forecast for 2033 (10 year), 3 predictions are offered for each month of 2033 with average Intellia Therapeutics stock
forecast of $24.0, a high forecast of $24.35, and a low forecast of $23.67.
The average Intellia Therapeutics stock forecast 2033 represents a -37.34%
decrease from the last price of $38.2999992370605.
Please, see more forecasts below.
NTLA : Intellia Therapeutics stock forecast by Wall Street Analysts
The average Intellia Therapeutics stock forecast from last 6 month is $97.23, and this show a -8.64% decrease in average from the prior price target of the each prediction. Also, this average forecast of $97.23 represents a -12.12% decrease from the past average forecast of $110.64, 6 months ago from 14 wall street analysts.
Intellia Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-03-28 | $39.45 | 3.00% |
| 2023-03-29 | $39.84 | 1.00% |
| 2023-03-30 | $40.45 | 1.52% |
| 2023-03-31 | $40.51 | 0.16% |
| 2023-04-03 | $40.26 | -0.62% |
NTLA : Long term Intellia Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Apr. is $38.03 , for 2024 Mar. is $39.00 , for 2027 Mar. is $63.40 , for 2028 Mar. is $73.91 , for 2032 Mar. is $30.74 , and for 2033 Mar. is $23.67.
NTLA : Intellia Therapeutics stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Apr. | $38.03 | -0.69% |
| 2023 May. | $37.83 | -0.53% |
| 2023 Jun. | $37.67 | -0.42% |
| 2023 Jul. | $37.60 | -0.20% |
| 2023 Aug. | $37.65 | 0.13% |
| 2023 Sep. | $37.79 | 0.39% |
| 2023 Oct. | $38.00 | 0.55% |
| 2023 Nov. | $38.28 | 0.73% |
| 2023 Dec. | $38.57 | 0.75% |
NTLA : Intellia Therapeutics stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $38.71 | 0.38% |
| 2024 Feb. | $38.87 | 0.40% |
| 2024 Mar. | $39.00 | 0.34% |
| 2024 Apr. | $39.14 | 0.36% |
| 2024 May. | $39.64 | 1.28% |
| 2024 Jun. | $40.17 | 1.35% |
| 2024 Jul. | $40.96 | 1.95% |
| 2024 Aug. | $40.34 | -1.52% |
| 2024 Sep. | $40.19 | -0.37% |
| 2024 Oct. | $40.07 | -0.30% |
| 2024 Nov. | $40.44 | 0.94% |
| 2024 Dec. | $41.08 | 1.56% |
NTLA : Intellia Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $42.09 | 2.46% |
| 2025 Feb. | $43.06 | 2.31% |
| 2025 Mar. | $44.21 | 2.67% |
| 2025 Apr. | $45.51 | 2.95% |
| 2025 May. | $46.53 | 2.24% |
| 2025 Jun. | $47.55 | 2.20% |
| 2025 Jul. | $48.16 | 1.28% |
| 2025 Aug. | $48.42 | 0.53% |
| 2025 Sep. | $48.36 | -0.11% |
| 2025 Oct. | $48.52 | 0.33% |
| 2025 Nov. | $48.98 | 0.94% |
| 2025 Dec. | $49.38 | 0.81% |
NTLA : Intellia Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $49.75 | 0.76% |
| 2026 Feb. | $50.14 | 0.78% |
| 2026 Mar. | $50.61 | 0.94% |
| 2026 Apr. | $51.24 | 1.25% |
| 2026 May. | $52.13 | 1.74% |
| 2026 Jun. | $53.20 | 2.05% |
| 2026 Jul. | $54.38 | 2.22% |
| 2026 Aug. | $55.76 | 2.53% |
| 2026 Sep. | $57.16 | 2.52% |
| 2026 Oct. | $58.51 | 2.36% |
| 2026 Nov. | $59.79 | 2.18% |
| 2026 Dec. | $60.89 | 1.85% |
NTLA : Intellia Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $61.83 | 1.54% |
| 2027 Feb. | $62.65 | 1.32% |
| 2027 Mar. | $63.40 | 1.20% |
| 2027 Apr. | $64.16 | 1.20% |
| 2027 May. | $64.97 | 1.26% |
| 2027 Jun. | $65.86 | 1.36% |
| 2027 Jul. | $66.81 | 1.44% |
| 2027 Aug. | $67.80 | 1.49% |
| 2027 Sep. | $68.80 | 1.47% |
| 2027 Oct. | $69.77 | 1.42% |
| 2027 Nov. | $70.72 | 1.36% |
| 2027 Dec. | $71.68 | 1.36% |
NTLA : Intellia Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $72.63 | 1.32% |
| 2028 Feb. | $73.40 | 1.06% |
| 2028 Mar. | $73.91 | 0.70% |
| 2028 Apr. | $74.28 | 0.49% |
| 2028 May. | $74.57 | 0.39% |
| 2028 Jun. | $74.84 | 0.37% |
| 2028 Jul. | $75.10 | 0.35% |
| 2028 Aug. | $75.34 | 0.32% |
| 2028 Sep. | $75.56 | 0.29% |
| 2028 Oct. | $75.74 | 0.24% |
| 2028 Nov. | $75.89 | 0.20% |
| 2028 Dec. | $76.01 | 0.16% |
NTLA : Intellia Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $76.09 | 0.11% |
| 2029 Feb. | $76.14 | 0.06% |
| 2029 Mar. | $76.16 | 0.02% |
| 2029 Apr. | $76.15 | -0.01% |
| 2029 May. | $76.12 | -0.04% |
| 2029 Jun. | $76.07 | -0.07% |
| 2029 Jul. | $75.98 | -0.11% |
| 2029 Aug. | $75.87 | -0.15% |
| 2029 Sep. | $75.72 | -0.20% |
| 2029 Oct. | $75.53 | -0.25% |
| 2029 Nov. | $75.31 | -0.30% |
| 2029 Dec. | $75.05 | -0.34% |
NTLA : Intellia Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $74.78 | -0.37% |
| 2030 Feb. | $74.49 | -0.39% |
| 2030 Mar. | $74.20 | -0.38% |
| 2030 Apr. | $73.93 | -0.36% |
| 2030 May. | $73.69 | -0.32% |
| 2030 Jun. | $73.49 | -0.27% |
| 2030 Jul. | $73.31 | -0.24% |
| 2030 Aug. | $73.12 | -0.26% |
| 2030 Sep. | $72.86 | -0.36% |
| 2030 Oct. | $72.46 | -0.56% |
| 2030 Nov. | $71.84 | -0.85% |
| 2030 Dec. | $70.95 | -1.24% |
NTLA : Intellia Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $69.72 | -1.72% |
| 2031 Feb. | $68.14 | -2.28% |
| 2031 Mar. | $66.17 | -2.88% |
| 2031 Apr. | $63.78 | -3.62% |
| 2031 May. | $60.63 | -4.94% |
| 2031 Jun. | $56.15 | -7.39% |
| 2031 Jul. | $50.65 | -9.79% |
| 2031 Aug. | $45.49 | -10.19% |
| 2031 Sep. | $41.53 | -8.72% |
| 2031 Oct. | $38.75 | -6.68% |
| 2031 Nov. | $36.73 | -5.20% |
| 2031 Dec. | $35.07 | -4.53% |
NTLA : Intellia Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $33.53 | -4.39% |
| 2032 Feb. | $32.08 | -4.33% |
| 2032 Mar. | $30.74 | -4.17% |
| 2032 Apr. | $29.52 | -3.96% |
| 2032 May. | $28.46 | -3.61% |
| 2032 Jun. | $27.55 | -3.18% |
| 2032 Jul. | $26.81 | -2.70% |
| 2032 Aug. | $26.21 | -2.21% |
| 2032 Sep. | $25.74 | -1.81% |
| 2032 Oct. | $25.35 | -1.52% |
| 2032 Nov. | $25.01 | -1.32% |
| 2032 Dec. | $24.69 | -1.27% |
NTLA : Intellia Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $24.35 | -1.40% |
| 2033 Feb. | $23.98 | -1.51% |
| 2033 Mar. | $23.67 | -1.30% |
Frequently Asked Questions about Intellia Therapeutics stock forecast
Is Intellia Therapeutics a good long term stock?
From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to Tudal, the Intellia Therapeutics stock price forecast for 2023 Apr. is $38.0341707082221 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to Tudal, the Intellia Therapeutics stock price forecast for 2024 Mar. is $38.9971082919518 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to Tudal, the Intellia Therapeutics stock price forecast for 2027 Mar. is $63.403699115405 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to Tudal, the Intellia Therapeutics stock price forecast for 2028 Mar. is $73.9142980888395 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to Tudal, the Intellia Therapeutics stock price forecast for 2032 Mar. is $30.7384047239012 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to Tudal, the Intellia Therapeutics stock price forecast for 2033 Mar. is $23.6708216453671
Is Intellia Therapeutics stock overvalued?
Intellia Therapeutics (NTLA) stock is expected to go UP . Therefore, Tudal would say that Intellia Therapeutics (NTLA) stock is NOT overvalued.
Will Intellia Therapeutics stock price go up?
Yes. The Intellia Therapeutics stock price forecast for 2024 Mar. is $38.9971082919518
Is Intellia Therapeutics stock a good buy now?
Since closing price on 2023-03-24 is $38.2999992370605 and forecast for 2024 Mar. is $39.00, Intellia Therapeutics stock is a good 1 year investment.